Kymera Therapeutics KYMR Earnings Call Transcripts

NASDAQ KYMR
$134.84 -1.80 (-1.32%)
At close: Nov 11, 2026 · 4:00 PM EST
4 earnings calls on file for Kymera Therapeutics, from Q3 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Kymera Therapeutics Q3 2026 Earnings Call

Oct 29, 2026 10,228 words · 44 min read
  • Justine KoenigsbergVice President of Investor Relations
  • Nello MainolfiFounder, President and Chief Executive Officer
  • Terence RooneyChief Medical Officer
  • Bruce JacobsChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Kymera Therapeutics Earnings Call Transcripts

Calls4
LatestOct 29, 2026
SinceQ3 2025

Fiscal 2026

Fiscal 2025

All 4 Kymera Therapeutics transcripts Register to get access to Kymera Therapeutics’s earnings call transcripts.